Facebook
X
LinkedIn
ForwardMayo Clinic Neuro-Oncology Summit: Translating Breakthroughs into Practice
This course offers Live (in-person) and Livestream (virtual) attendance options.
Course Directors: Wendy Sherman, M.D., Alfredo Quinones-Hinojosa, M.D., Maciej Mrugala, M.D., Ph.D., Terry Burns, M.D., Ph.D. and Rich Byrne, M.D.
February 26 - 27, 2027 - Mayo Clinic - Kinne Auditorium - Jacksonville, Florida
This course covers advanced topics in neuro-oncology, offering a review of advances in diagnosis and treatment of individuals with nervous system tumors. The course covers the latest advances in neurosurgery, radiation oncology, neurology, and medical oncology, discussing novel therapeutic approaches that are transforming clinical practice with personalized treatments.
Abstract Submissions - Deadline November 20, 2026
As part of the Mayo Clinic Neuro-Oncology Summit, a Poster Session for presentation of original research and challenging cases dedicated to the fields
of cancer neuroscience and neuro-oncology will be held at this meeting.
Accepted abstract recipients will be chosen from all abstracts received by the submission deadline. Registration is required for all accepted poster presenters. For further information email sanchez.anna2@mayo.edu
Abstract Submission Webform
| Registration Fee(s) | |
|---|---|
| M.D., D.O., Ph.D. | $500 |
| Allied Health, NP, PA, Retirees | $400 |
Target Audience
This course is designed for Physicians, Physician Assistants, Nurse Practitioners, and Residents interested in novel therapeutic strategies for improving care for all individuals with nervous system tumors.
Learning Objectives
Upon completion of the course, learners should be able to:
- Discuss novel therapeutics for treatment of primary CNS tumors.
- Discuss novel therapeutics for tumor-predisposing conditions with nervous system involvement.
- Discuss state-of-the-art diagnostic and therapeutic options for malignant CNS tumors.
- Evaluate the impact of molecular features on tumor behavior, therapeutic selection, and response to therapy.
- Recognize the value of a multidisciplinary approach to patients with CNS tumors.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Additional Information
| Attachment | Size |
|---|---|
 Mayo Clinic Neuro-Oncology Summit Agenda .pdf | 171.45 KB |
Course summary
- 9.75 ABS - Accredited CME
- 9.75 ABS - Self-Assessment
- 9.75 AMA PRA Category 1 Credit™
- 9.75 ANCC
- 9.75 Attendance
Friday, February 26, 2027 | |
7:00 - 8:00 a.m. | Registration & Continental Breakfast |
8:00 - 8:10 a.m. | Welcome Wendy Sherman, M.D. |
Moderator: Wendy Sherman, M.D. | |
8:10 – 8:30 a.m.
| Beyond WHO 2021: Emerging Biomarkers and Epigenomic Classifications in Low-Grade Glioma |
8:30 – 8:50 a.m.
| PET Imaging in Neuro-Oncology: Recent Advances and Appropriate Use Derek Johnson, M.D. |
8:50 – 9:10 a.m. | Longitudinal Glioma Monitoring via Liquid Biopsies: Mayo Clinic Experience Terry Burns, M.D., Ph.D |
9:10 – 9:20 a.m. | Interactive Q & A Panel |
9:20 – 9:35 a.m. | Refreshment Break & Exhibits |
Low Grade Glioma Part 2 Moderator: Ugur Sener M.D. | |
9:35 – 9:55 a.m.
| Modern Radiation Therapy Strategies for Low-Grade Glioma: Optimizing Control and Minimizing Toxicity confirmed Kevin Zhang, M.D. |
9:55 – 10:15 a.m.
| Point/Counterpoint: IDH Inhibition Wendy Sherman, M.D. & Shannon Fortin Ensign, M.D., Ph.D. |
10:15 – 10:35 a.m. | Tumor Board Speakers from Part 1 and Part 2 |
10:35 – 10:50 a.m. | Interactive Q & A Panel |
10:50 - 11:05 a.m. | Refreshment Break & Exhibits |
Moderator: Christine Cordova, M.D. | |
11:05 – 11:25 a.m.
| Targetable Pathways and Novel Therapeutics in Glioblastoma confirmed Sani Kizilbash, M.D., M.P.H. |
11:25 – 11:45 a.m.
| Immunotherapy in High-Grade Glioma: Overcoming Microenvironmental Resistance confirmed Jian Campian, M.D., Ph.D. |
11:45 a.m. – 12:05 p.m. | CAR-T Cell Therapy for High-Grade Glioma: Translational Advances and Clinical Engineering confirmed change Hong Qin, M.D., Ph.D. |
12:05 – 12:20 p.m. | Interactive Q & A Panel |
12:20 – 1:20 p.m. | Lunch, Networking, Exhibits and Poster Session |
Survivorship Moderator: Maisha Robinson, M.D. | |
1:20 – 1:40pm | Innovations in Neuro-Rehabilitation: Restoring Function in Brain Tumor Patients confirmed Geneveive Marshall, D.O. |
1:40 - 2:00 p.m. | Integrated Palliative Care in Neuro-Oncology: Early Intervention and Quality of Life emailed Maisha Robinson, M.D. |
2:00 – 2:20 p.m. | Protecting the Brain: Neuro-Cognitive Preservation, Remediation, and Compensation Strategies Leslie Baxter, Ph.D. |
2:20 – 2:40 p.m. | Interactive Q&A |
2:40 p.m. | Closing & Thank you, see you tomorrow |
Saturday, February 27, 2027 | |
7:00 - 8:00 a.m. | Registration & Continental Breakfast |
8:00 – 8:10 a.m. | Welcome Wendy Sherman, M.D. |
Skull Base Moderator: Terry Burns, M.D., Ph.D. | |
8:10 – 8:30 a.m.
| Translational Meningioma Research: Bench-to-Bedside Target Discovery Victoria Clark, M.D., Ph.D. |
8:30 – 8:50 a.m.
| Targeted Radiation Paradigms for Complex Meningioma Dan Trifiletti, M.D. |
8:50 – 9:10 a.m.
| Craniopharyngioma: Updates in Endocrine and Precision Medical Management Susan Samson, M.D., Ph.D. |
9:10 – 9:30 a.m.
| Surgical Paradigms in Skull Base Tumors and Neurofibromatosis Type 1 Gelareh Zadeh, M.D., Ph.D. |
9:30 – 9:45 a.m. | Interactive Q & A |
9:45 – 10:00 a.m. | Refreshment Break & Exhibits |
Brain Mets Moderator: Daniel Trifiletti, MD | |
10:00 – 10:20 a.m. | SRS and Beyond: Maximizing Local Control and Minimizing Radionecrosis in Brain Metastases Jennifer Peterson, M.D. |
10:20 – 10:40 a.m.
| Systemic and Targeted Therapies for Central Nervous System Metastases (TBD) Alyx Porter, M.D. (TBD) |
10:40 – 11:00 a.m. | Leptomeningeal Disease: Current Standard of Care and Emerging Therapeutic Pipelines Maciej Mrugala, M.D., Ph.D. |
Tumor Board Peterson, Porter (TBD), Mrugala | |
11:20 – 11:40 a.m. | Interactive Q &A |
12:00 – 1:00 p.m. | Lunch, Networking, & Exhibits |
Innovation Moderators: Maciej Mrugala, M.D., Ph.D. | |
1:00 – 1:20 p.m.
| AI-Driven Clinical Trial Design and Expanding Access with Remote Neuro-Oncology Care Ugur Sener, M.D. |
1:20 – 1:40 p.m. | Device Innovations in Neuro-Oncology: Tumor Treating Fields and Beyond Michael Ruff, M.D. |
1:40 – 2:00 p.m. | AI Applications in Molecular Diagnostics and Neuropathology Ken Aldape, M.D. |
2:00 – 2:20 p.m. | Targeting the Engine of Glioblastoma: The Discovery, Preclinical Development, and Clinical Translation of MT-125 Steve Rosenfeld, M.D., Ph.D. |
2:20 - 2:40 p.m. | Interactive Q &A |
2:40 p.m. | Ending / Closing - Thank you |
All travel and lodging expenses are the sole responsibility of the individual registrant.
Nearby Hotels
Residence Inn by Marriott Jacksonville - Mayo Clinic Area
Distance from Kinne Auditorium: .8 miles
Hilton Jacksonville at Mayo Clinic
Distance from Kinne Auditorium: 1 mile
Four Points by Sheraton Jacksonville Beachfront
Distance from Kinne Auditorium: 5 miles
Kenneth Aldape, M.D.
Leslie Baxter, Ph.D.
Jian Campian, M.D., Ph.D.
Victoria Clark, M.D., Ph.D.
Shannon Fortin Ensign, M.D., Ph.D.
Sani Kizilbash, M.D., M.P.H.
Genevieve Marshall, D.O.
Jennifer Peterson, M.D.
Hong Qin, M.D., Ph.D.
Maisha Robinson, M.D.
Michael Ruff, M.D.
Susan Samson, M.D., Ph.D.
Ugur Sener, M.D.
Daniel Trifiletti, M.D.
Gelareh Zadeh, M.D., Ph.D.
Kevin Zhang, M.D.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 9.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 9.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
| Day Attended: | Credits: |
| Friday | 5.0 |
| Saturday | 4.75 |
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 9.75 ABS - Accredited CME
- 9.75 ABS - Self-Assessment
- 9.75 AMA PRA Category 1 Credit™
- 9.75 ANCC
- 9.75 Attendance
This course offers the unique opportunity for a variety of sponsorship opportunities, including the ability to interact with healthcare providers and highlight products and services through an exhibit. The letter of request and sponsorship descriptions can be found in the attached prospectus. Space is limited and reserved upon receipt of a completed agreement.
If you are interested in sponsoring or exhibiting at the Mayo Clinic Neuro-Oncology Summit: Translating Breakthroughs into Practice complete the appropriate Letter of Agreement via the link(s) below, prior to December 10, 2026. If you do not have a profile/account you will first need to create one before completing the online form:
Note: Exhibitors must be logged into https://ce.mayo.edu prior to completing the above submission form. To create an exhibitor profile, please follow the instructions located here.
- If you are interested in participating, please complete the Exhibit letter of Agreement.
Contact: Latasha Bunkley with questions.
| Registration Fee(s) | |
|---|---|
| M.D., D.O., Ph.D. | $500 |
| Allied Health, NP, PA, Retirees | $400 |
Before registering, please update your profile
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Belonging and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which all individuals are valued, allowing all to achieve their fullest potential.
Every effort will be made to accommodate dietary requirements; however, some requests may not be feasible based on venue kitchen capabilities. Attendees will be contacted in advance if a dietary restriction cannot be fulfilled.
The Mayo Clinic School of Continuous Professional Development strives for fully accessible learning experiences. If you anticipate any barriers while attending this course, please reach out to the course coordinator who will be in touch with all registrants. If you need disability-related accommodations, please contact the Office of Wellness and Academic Support – Disability Access Services at MCCMS.DS@mayo.edu.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.